Sanofi (ENXTPA:SAN) has recently announced it will begin shipping Beyfortus in early Q3 2025. This move aims to support healthcare providers ahead of the RSV season. Sanofi's commitment to increasing ...

MSD's Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in US infants.

Der Pharmakonzern erhält die wichtige US-Zulassung für ein Vakzin. Der dortige Gesundheitsminister wird derweil seinem Ruf ...

In this week’s edition of InnovationRx, we look at RFK Jr.’s vaccine advisory committee purge, a tech billionaire’s funding ...

Eigentlich sollte Gabriel nach seiner Geburt eine RSV-Impfung bekommen. Doch das Geburtskrankenhaus gab sie ihm nicht und der ...

MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.

RAHWAY, N.J. - Merck Animal Health, eine Abteilung von Merck & Co. (NYSE: MRK ), die laut InvestingPro -Daten eine "HERVORRAGENDE" finanzielle Gesundheitsbewertung von 3,24 aufweist, gab am Donnerstag ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower ...

Merck scored a major win with FDA approval for Enflonsia, its fresh RSV-fighting antibody aimed at shielding infants. This ...